title: Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients.
authors.forename: D
authors.initials: D
authors.lastname: Memiş
authors.forename: S
authors.initials: S
authors.lastname: Hekimoğlu
authors.forename: I
authors.initials: I
authors.lastname: Vatan
authors.forename: T
authors.initials: T
authors.lastname: Yandim
authors.forename: M
authors.initials: M
authors.lastname: Yüksel
authors.forename: N
authors.initials: N
authors.lastname: Süt
mesh_terms: D016638:Critical Illness / Q000628:therapy; D020927:Dexmedetomidine / Q000494:pharmacology*; D005745:Gastric Acidity Determination; D005753:Gastric Mucosa / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D018836:Inflammation Mediators / Q000097:blood; D008874:Midazolam / Q000494:pharmacology*; D018805:Sepsis / Q000628:therapy*
chemical_list: D006993:Hypnotics and Sedatives; D018836:Inflammation Mediators; D020927:Dexmedetomidine; D008874:Midazolam